BRIEF-Seres Therapeutics Q3 net loss per share $0.17 By: Reuters: Company News November 08, 2017 at 07:14 AM EST * Seres Therapeutics reports third quarter 2017 financial results and provides update on operational progress Read More >> Related Stocks: Seres Therapeutics Inc